It's all about the enzymes. Strike that. More precisely, much drug development these days seems to be about the enzymes, as replacement therapies and as treatments.

The sarcastic phrase in everyday life is often used to imply the opposite of its literal meaning, but a big deal is what many smaller biotechnology companies live for - and some can't live without. (BioWorld Financial Watch)